Assessing Houlihan Lokey (HLI) Valuation After Recent Weak Share Price Performance

Why Houlihan Lokey is on investors’ radar today

Houlihan Lokey (HLI) has drawn attention after a period of weaker share performance, with the stock showing negative returns over the past month, past 3 months, year to date, and over the past year.

In this context, investors are reassessing the US$9.8b investment bank’s fundamentals, including its US$2,648.0m in revenue, US$447.8m in net income, and a value score of 4, to gauge whether current pricing reflects its underlying advisory business mix.

See our latest analysis for Houlihan Lokey.

Houlihan Lokey’s recent 30 day share price return of -17.16%, alongside a -21.16% return year to date, contrasts with a stronger 3 year total shareholder return of 62.98% and 5 year total shareholder return of 126.46%. This suggests that recent momentum has faded even though longer term holders have still seen meaningful gains.

If this kind of reset in sentiment has you thinking about where else to look, it could be a good moment to broaden your search with 20 top founder-led companies

With Houlihan Lokey trading below some analyst price targets and recent returns looking weak against its longer term record, are you looking at a reset that creates an opportunity, or is the market already pricing in future growth?

Most Popular Narrative: 34.1% Undervalued

Houlihan Lokey's most followed narrative pegs fair value at about $210.86 per share, compared with a last close of $139.02, and builds its case around future earnings power and profitability.

Ongoing global expansion, sector diversification, and talent recruitment position Houlihan Lokey for sustained revenue growth and increased market share. Strong pipelines from succession planning, resilient restructuring activity, and enhanced client engagement are stabilizing fee income and supporting earnings despite macroeconomic shifts.

Read the complete narrative.

Curious how that gap between price and fair value is justified? The narrative leans heavily on compounded revenue growth, firmer margins, and a richer earnings multiple tied to those cash flows.

Result: Fair Value of $210.86 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, you also need to weigh the risk that high compensation and other expenses, together with reliance on US-focused M&A trends, could pressure margins and deal flow.

Find out about the key risks to this Houlihan Lokey narrative.

Another Take on Valuation: What the P/E Says

The fair value narrative and analyst targets both lean on growth and cash flow assumptions, but the current price also reflects what investors are willing to pay per dollar of earnings today. On that score, Houlihan Lokey trades on a P/E of 21.7x.

That is cheaper than the wider US Capital Markets industry at 29.6x, yet higher than direct peers at 14.8x and above an estimated fair ratio of 15.1x. This raises the question of whether this reflects a quality premium that may be maintained, or a valuation that could potentially compress if sentiment cools.

See what the numbers say about this price — find out in our valuation breakdown.

Next Steps

Seen enough mixed signals to know this is not a one sided story? The quickest way to stress test your own view is to look at both the risks and the potential upside that others are focused on, starting with 5 key rewards and 1 important warning sign

Looking for more investment ideas?

If Houlihan Lokey has sharpened your thinking, do not stop here. Fresh ideas from curated stock lists can help you pressure test and refine your next move.

• Target income potential by scanning companies in the 13 dividend fortresses for ideas that pair higher yields with supporting fundamentals.
• Hunt for quality at a reasonable price by checking the 58 high quality undervalued stocks that screens for fundamentals-backed opportunities.
• Prioritize sleep at night potential by reviewing the 73 resilient stocks with low risk scores and seeing which companies show lower risk scores based on key metrics.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com